Presence of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinase in human sperm

被引:0
|
作者
Buchman-Shaked, O
Kraiem, Z
Gonen, Y
Goldman, S
机构
[1] Carmel Hosp, Endocrine Res Unit, IL-34362 Haifa, Israel
[2] Technion Israel Inst Technol, Fac Med, Haifa, Israel
[3] Haemek Med Ctr, IVF Unit, Afula, Israel
来源
JOURNAL OF ANDROLOGY | 2002年 / 23卷 / 05期
关键词
fertilization; oligo-terato-asthenospermia; infertility;
D O I
暂无
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
The matrix metalloproteinases (MMPs) are a family of proteolytic enzymes that degrade protein components of the extracellular matrix. The necessity of breakdown of physical barriers in the fertilization process suggests that MMPs, along with their tissue inhibitors (TIMPs), might be involved in this task. We have examined the presence of MMP and TIMP in normal and abnormal human sperm samples by gel zymography and Western blot analysis. Thirty-five normal sperm samples and 35 abnormal sperm samples were examined in this study. Gel zymography showed 92-, 72-, 62-, and 28-kd molecular-weight bands exhibiting gelatin-degrading activity in both normal and abnormal sperm samples. The 92-, 72-, and 62-kd bands with gelatinolytic activity are consistent with pro-MMP-9, pro-MMP-2, and active MMP-2, respectively (pro-MMP being the zymogen of MMP). Western blot analysis showed the presence of TIMP-1 in both normal and abnormal sperm samples. A higher 28-kd activity and a lower 92-kd MMP activity in normal sperm samples relative to abnormal samples were detected. No marked difference in TIMP-1, 72-kd, and 62-kd release was observed between normal and abnormal sperm samples. In conclusion, this is the first report of MMP activity in normal and abnormal human sperm samples and of TIMP presence in sperm samples. The data indicate a different MMP profile between normal and abnormal sperm samples, with a higher 28-kd activity and a lower 92-kd MMP activity in normal relative to abnormal samples.
引用
收藏
页码:702 / 708
页数:7
相关论文
共 50 条
  • [41] Matrix Metalloproteinase and Tissue Inhibitor of Metalloproteinases Is Associated with Multiple Myeloma Progression, Prognosis and Extramedullary Plasmacytoma
    Ishihara, Rei
    Murakami, Yuki
    Homma, Kazuki
    Watanabe, Saki
    Oda, Tsukasa
    Sunaga, Masanobu
    Yamane, Eiko
    Kobayashi, Nobuhiko
    Osaki, Yohei
    Ishizaki, Takuma
    Shimizu, Hiroaki
    Iriuchishima, Hirono
    Koiso, Hiromi
    Tsukamoto, Norifumi
    Yokohama, Akihiko
    Nanami, Gotoh
    Ino, Rumi
    Saitoh, Takayuki
    Murakami, Hirokazu
    Handa, Hiroshi
    BLOOD, 2018, 132
  • [42] Altered matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 levels in children with primary hypertension
    Niemirska, Anna
    Litwin, Mieczyslaw
    Trojanek, Joanna
    Gackowska, Lidia
    Kubiszewska, Izabela
    Wierzbicka, Aldona
    Kulaga, Zbigniew
    Michalkiewicz, Jacek
    JOURNAL OF HYPERTENSION, 2016, 34 (09) : 1815 - 1822
  • [43] MATRIX METALLOPROTEINASES AND TISSUE INHIBITOR OF METALLOPROTEINASES - A REVIEW OF THEIR ROLE IN TUMORIGENESIS AND TISSUE INVASION
    KHOKHA, R
    DENHARDT, DT
    INVASION & METASTASIS, 1989, 9 (06): : 391 - 405
  • [44] Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma
    Nakada, M
    Kita, D
    Futami, K
    Yamashita, Y
    Fujimoto, N
    Sato, H
    Okada, Y
    JOURNAL OF NEUROSURGERY, 2001, 94 (03) : 464 - 473
  • [45] Induction of mRNA for matrix metalloproteinase 1 and tissue inhibitor of metalloproteinases 1 in human skin in vivo by solar simulated radiation
    Lahmann, C
    Young, AR
    Wittern, KP
    Bergemann, J
    PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2001, 73 (06) : 657 - 663
  • [46] Effects of indomethacin on the production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by human articular chondrocytes
    Yamada, H
    Kikuchi, T
    Nemoto, O
    Obata, K
    Sato, H
    Seiki, M
    Shinmei, M
    JOURNAL OF RHEUMATOLOGY, 1996, 23 (10) : 1739 - 1743
  • [47] MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF METALLOPROTEINASES IN HUMAN GLIOMAS
    NAKANO, A
    TANI, E
    MIYAZAKI, K
    YAMAMOTO, Y
    FURUYAMA, JI
    JOURNAL OF NEUROSURGERY, 1995, 83 (02) : 298 - 307
  • [48] REGULATION OF TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE EXPRESSION
    OVERALL, CM
    INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL, 1994, 732 : 51 - 64
  • [49] COEXPRESSION OF TISSUE INHIBITOR AND MATRIX METALLOPROTEINASE IN MYOCARDIUM
    TYAGI, SC
    KUMAR, SG
    BANKS, J
    FORTSON, W
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1995, 27 (10) : 2177 - 2189
  • [50] Tissue inhibitors of metalloproteinases are proteolytic targets of matrix metalloproteinase 9
    Coates-Park, Sasha
    Lazaroff, Carolyn
    Gurung, Sadeechya
    Rich, Josh
    Colladay, Alexandra
    O'Neill, Maura
    Butler, Georgina S.
    Overall, Christopher M.
    Stetler-Stevenson, William G.
    Peeney, David
    MATRIX BIOLOGY, 2023, 123 : 59 - 70